Abstract:Objective To test whether activation of CB2 receptor would induce antinociception and investigate the role of in-trathecal JWH015 in the modulation of Tyr-1472 phosphorylation of the spinal NR2B subunit in a model of neuropathic pain. Meth-otis 84 male SD rats with intrathecal catheter insertion were randomly divided into 3 groups: sham + 50% DMSO group (Sham group); CCD + 50%DMSO group(Vehicle group); CCD+JWH015 group(JWH015 group). Seven days after Sham or CCD(without in-trathecal injection), the lumbosacral spinal cords of 6 Sham rats and 6 CCD rats were collected for immunohistochemical study to de-termine the spinal expression of Tyr-1472 phosphorylated NR2B subunit(baseline). The rest were intrathcally injected with 50%DMSO 10 μl or JWH015 10 μg seven days after Sham or CCD. For behavioral studies, the data of paw withdrawal mechanical threshold (PWMT) and paw withdrawal thermal latency (PWTL) were measured in Sham group or CCD group, before intrathecal injection and 1, 2, 4, 8, 24, 72 h after intrathecal injection (n=6). For immunohistochemical study, the lumbosacral spinal cords were collected 4, 8, 24, 72 h after intrathecal injection(n=6). Results Compared with the baseline before operation, the PWMT and the PWTL of Vehicle group and JWHOI5 group began to decrease before intrathecal injection(P<0.01). Compared with Vehicle group, PWMT and PWTL of JWH015 group increased markedly 1, 2 and 4 h after intrathecal injection (P0.05). Tyr-1472 phosphorylated NR2B subunit expression in the superficial dorsal horn was weak in all sham groups, but increased significantly 7 days after CCD. While intrathecal 50%DMSO did not decrease the expres-sion of Tyr-1472 phosphorylated NR2B subunit in the superficial dorsal horn, the expression of Tyr-1472 phosphorylated NR2B sub-unit in the superficial dorsal horn decreased obviously 4 h and 8 h after intrathcal JWH015. However, the expression of Tyr-1472 phosphorylated NR2B subunit in the superficial dorsal horn increased again 24 h and 72 h after intrathcal JWH015. Conclusion In-trathecal administration of CB2 receptor agonist JWHOI5 may provide analgesic effect, which is probably attributed to the decrease in the spinal expression of Tyr-1472 phosphorylated NR2B subunit.

The Effect of Cannabinoid Receptor 2 Agonist JWH015 on the Hyperalgesia Induced by Remifentanil

Effect of Intrathecal Injection JWH015 on the Remifentani-Induced Hyperalgesia in Rats

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

[Effects of Intrathecal Transient Receptor Potential Vanilloid 1 Blocker on Cervical Distension Induced Visceral Pain Response].

Intrathecal injection of JWH015 attenuates remifentanil-induced postoperative hyperalgesia by inhibiting activation of spinal glia in a rat model.

Effects of Intrathecal Morphine on Excitatory Amino Acid Contents of Spinal Cord in a Rat Model of Incision Pain

Effects of Ketamine Pretreatment on Preventing Remifentanil-Induced Hyperalgesia

Antinflammatory pain effect of ifenprodil administrated subarachnoidly

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

Effect of Tramadol on Immune Responses and Nociceptive Thresholds in a Rat Model of Incisional Pain.

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

Effect of Verapamil on Expression of K+·Cl-cotransporter 2 in Spinal Dorsal Horns During Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

The Preventive Effect of Intrathecal KN93 or Ifenprodil Administration on Remifentanil-Induced Incisional Hyperalgesia

Effects of Dexmedetomidine on Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

Antinociception and Prevention of Hyperalgesia by Intrathecal Administration of Ro 25-6981, a Highly Selective Antagonist of the 2B Subunit of N-methyl-d-aspartate Receptor

Effect of Transient Receptor Potential A1 Antagonists on Post-Operation Pain in a Rat Model of Incisional Pain

[Changes of Mu-opioid receptor and neuron-restrictive silencer factor in periaquductal gray in mouse models of remifentanil-induced postoperative hyperalgesia]

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

The Antinociceptive Effect of Intrathecal CB2 Cannabinoid Receptor Agonist (JWH015) in Rats with Chronic Compression of the Dorsal Root Ganglia

The Influence of Ketamine on KCC2 in Spinal Cord of Rat in Remifentanil-Induced Hyperalgesia

Effects of cyclin dependent kinase 5 inhibitor Roscovitine on remifentanil-induced hyperalgesia